Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Fidia Farmaceutici s.p.a. clinical trials
Part of P&R Farmaceutici S.p.A., which holds 95.3% as of 2022-12-31. Source
The registry lists 37 studies whose lead sponsor is Fidia Farmaceutici s.p.a. or one of 3 companies grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.
Keep track of what changes. Save the Fidia Farmaceutici s.p.a. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Fidia Farmaceutici s.p.a..
- Fidia Farmaceutici s.p.a.32 studiesSame company
Something wrong?
- Sooft Italia3 studies →Acquired
Something wrong?
- Altacor Ltd.1 study →Acquired
Something wrong?
- Fidia Pharma USA Inc.1 study →Regional office
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 37 of 37.
- Assessment of Efficacy of a Single Intra-articular Injection of HYALUBRIX 60 in Knee OsteoarthritisRecruitingNCT06113783Not applicable
- Management of Acute and Chronic Wounds With Hyaluronic AcidRecruitingNCT06108999Not applicable
- Safety of Liposom With Citalopram in Elderly Patients With Major Depressive DisorderRecruitingNCT04975724Phase 4
- Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic WoundsRecruitingNCT06103812
- Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back PainRecruitingNCT04585334Phase 4
- Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of InfectionRecruitingNCT04936204Not applicable
- Clinical Investigation to Evaluate the Performance of Hyaluronic Acid for the Treatment of Hypertrophic ScarsRecruitingNCT04614415Not applicable
- An Open Label, Randomized-controlled Trial to Assess Efficacy Safety of HYALODISC With Physical Exercise ProgramRecruitingNCT04757038Not applicable
- Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant TreatmentCompletedNCT07431385Not applicable
- Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye DiseaseCompletedNCT06190054Not applicable
- Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT06210373Not applicable
- Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%CompletedNCT06189456Not applicable
- Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)Active, not recruitingNCT05024773Phase 3
- Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral OsteoarthritisActive, not recruitingNCT07520708Not applicable
- Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive TherapyTerminatedNCT06190028Not applicable
- Evaluation of the Performance and Safety of Hyalo Gyn® Gel Compared to Placebo in Postmenopausal Breast Cancer SurvivorsActive, not recruitingNCT06922136Not applicable
- Comparative Study of Two Hyaluronic Acid Formulation in the Management of Knee OsteoarthritisCompletedNCT06528600Not applicable
- Investigation to Evaluate the Clinical Safety and Effectiveness of WET® GelCompletedNCT04358055Not applicable
- Clinical Investigation to Evaluate the Safety and Efficacy of Dressing CONNETTIVINA HI TECH in the Management of Superficial Cutaneous LesionsTerminatedNCT04652752Not applicable
- Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.TerminatedNCT06069453Not applicable
- Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the LimbsCompletedNCT04976088Phase 3
- Efficacy and Safety of the Use of Ophthalmic Viscosurgical Devices (OVD) FIDIAL PLUS vs IAL®-F During Cataract SurgeryCompletedNCT06062771Not applicable
- Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID)CompletedNCT04798703Phase 1
- ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.CompletedNCT04661826Phase 2
- Efficacy and Safety of Hymovis ONE® (32mg/4ml) Intrarticular Injection in Active Patients With Knee Overuse SyndromeCompletedNCT04661111Not applicable
- Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy VolunteersCompletedNCT01531699Phase 3
Sponsor listed in the registry: Altacor Ltd. · Altacor Ltd. — acquired company within the Fidia Farmaceutici s.p.a. group
- Early Administration of the Lutein/Zeaxanthin in Premature NewbornsWithdrawnNCT03340103Not applicable
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group
- Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a DayCompletedNCT04585321Phase 1
- 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)CompletedNCT03281837Not applicable
Sponsor listed in the registry: Fidia Pharma USA Inc.
- A Multicentre Clinical Investigation to Assess Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Chondroitin Sulfate in Knee OsteoarthritisCompletedNCT04358120Not applicable
- Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal WomenCompletedNCT04355403Not applicable
- Evaluation of the Evolution of Biological and Imaging Markers of Bone and Cartilage Degradation in Patients With Knee Osteoarthritis Receiving Intra-articular Injections of a Hyaluronan Derivative HYMOVIS®CompletedNCT04293861Not applicable
- Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause WomenCompletedNCT03557398Not applicable
- Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the KneeStatus unknownNCT02187549Not applicable
- Hymovis™ Versus Placebo in Knee OsteoarthritisCompletedNCT01372475Phase 3
- Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical TherapyWithdrawnNCT00864578
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group
- Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye DropsWithdrawnNCT00863811
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group